Edward Albini

Edward Albini

Chief Financial OfficeratSutro Biopharma· In proxies 2023–2024

Pay in FY2024+15% from the year before · Sutro Biopharma stock -57.1% the same year

Edward Albini was paid $1.2M in FY2024 (Dec), up 15%. Sutro Biopharma stock fell 57.1% that year.

Pay$100 in the stock at the end of FY22 → $23
Pay is from the Summary Compensation Table of each Sutro Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sutro BiopharmaPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role -86%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?